MADISON, N.J., Sept. 21 /PRNewswire-FirstCall/ -- Wyeth announced today that it will present at the UBS Global Life Sciences Conference on Tuesday, September 26, 2006 at 10:00 a.m. Eastern Time. Presenting for Wyeth will be Justin R. Victoria, Vice President, Investor Relations.
Wyeth’s presentation will be webcast live for investors at http://www.wyeth.com and available for replay following the conference.
Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and non-prescription medicines that improve the quality of life for people worldwide. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare, and Fort Dodge Animal Health.
Wyeth
CONTACT: Media Contact: Doug Petkus, +1-973-660-5218, or Investor Contact:Justin Victoria, +1-973-660-5340 , both of Wyeth
Web site: http://www.wyeth.com/
